260 related articles for article (PubMed ID: 30096136)
1. Antipsychotic prescribing patterns on admission to and at discharge from a tertiary care program for treatment-resistant psychosis.
Lee LHN; Procyshyn RM; White RF; Woodward TS; Honer WG; Barr AM
PLoS One; 2018; 13(8):e0199758. PubMed ID: 30096136
[TBL] [Abstract][Full Text] [Related]
2. Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital.
Stone-Brown K; Naji M; Francioni A; Myers K; Samarendra H; Mushtaq-Chaudhry H; Heslop S; Sengupta S; Ross CC; Larkin F; Das M
CNS Spectr; 2016 Feb; 21(1):60-9. PubMed ID: 26726766
[TBL] [Abstract][Full Text] [Related]
3. Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study.
Wheeler AJ; Hu J; Profitt C; McMillan SS; Theodoros T
BMC Psychiatry; 2020 Jun; 20(1):294. PubMed ID: 32527250
[TBL] [Abstract][Full Text] [Related]
4. Maintenance phase treatment of psychotic disorders in outpatients from Serbia - focus on long-term benzodiazepine use.
Marić NP; Andrić Petrović S; Jerotić S; Ristić I; Savić B; Zebić M; Vuković V; Britvić D; Golubović O; Jakšić M; Jevđić K; Kolašinac Z; Lalović N; Mirković Ilić J; Nikolić S; Paunović Č; Pavlović Z; Pejović Nikolić S; Perović V; Popović J; Ranđić Avakumović V; Stojanović S; Tatarević M; Živković I; Voskresenski T; Jovanović N
Int J Psychiatry Clin Pract; 2020 Sep; 24(3):315-321. PubMed ID: 32459564
[No Abstract] [Full Text] [Related]
5. Antipsychotic prescribing pathways, polypharmacy, and clozapine use in treatment of schizophrenia.
Gören JL; Meterko M; Williams S; Young GJ; Baker E; Chou CH; Kilbourne AM; Bauer MS
Psychiatr Serv; 2013 Jun; 64(6):527-33. PubMed ID: 23450334
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization.
Saldaña SN; Keeshin BR; Wehry AM; Blom TJ; Sorter MT; DelBello MP; Strawn JR
Pharmacotherapy; 2014 Aug; 34(8):836-44. PubMed ID: 24990538
[TBL] [Abstract][Full Text] [Related]
7. [Prescription practices of antipsychotic medication in early psychosis: a two-year follow-up survey of subjects admitted in two psychiatric hospitals of South-Western France].
Grolleau A; Cougnard A; Parrot M; Kalmi E; Desage A; Misdrahi D; Brun-Rousseau H; Verdoux H
Encephale; 2007; 33(3 Pt 1):326-31. PubMed ID: 17675930
[TBL] [Abstract][Full Text] [Related]
8. The hidden magnitude of polypharmacy: using defined daily doses and maximum licensed daily doses to measure antipsychotic load.
Nguyen ML; Sunderland B; Lim S; Hattingh L; Chalmers L
Int J Clin Pharm; 2019 Dec; 41(6):1642-1651. PubMed ID: 31677120
[TBL] [Abstract][Full Text] [Related]
9. Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review.
Taylor DM; Young C; Paton C
J Clin Psychiatry; 2003 Jan; 64(1):30-4. PubMed ID: 12590620
[TBL] [Abstract][Full Text] [Related]
10. Audit of antipsychotic prescribing in a private psychiatric hospital.
Botvinik L; Ng C; Schweitzer I
Australas Psychiatry; 2004 Sep; 12(3):227-33. PubMed ID: 15715780
[TBL] [Abstract][Full Text] [Related]
11. Determinants of antipsychotic polypharmacy in psychiatric inpatients: a prospective study.
Biancosino B; Barbui C; Marmai L; Donà S; Grassi L
Int Clin Psychopharmacol; 2005 Nov; 20(6):305-9. PubMed ID: 16192838
[TBL] [Abstract][Full Text] [Related]
12. Early use of clozapine for poorly responding first-episode psychosis.
Agid O; Remington G; Kapur S; Arenovich T; Zipursky RB
J Clin Psychopharmacol; 2007 Aug; 27(4):369-73. PubMed ID: 17632221
[TBL] [Abstract][Full Text] [Related]
13. Real-World Outcomes in the Management of Refractory Psychosis.
Krivoy A; Joyce D; Tracy D; Gaughran F; MacCabe J; Lally J; Whiskey E; Sarkar SN; Shergill SS
J Clin Psychiatry; 2019 Sep; 80(5):. PubMed ID: 31556974
[TBL] [Abstract][Full Text] [Related]
14. The risks and benefits of switching patients with schizophrenia or schizoaffective disorder from two to one antipsychotic medication: a randomized controlled trial.
Constantine RJ; Andel R; McPherson M; Tandon R
Schizophr Res; 2015 Aug; 166(1-3):194-200. PubMed ID: 26141142
[TBL] [Abstract][Full Text] [Related]
15. Patterns of antipsychotic prescription to patients with schizophrenia in Korea: results from the health insurance review & assessment service-national patient sample.
Park SC; Lee MS; Kang SG; Lee SH
J Korean Med Sci; 2014 May; 29(5):719-28. PubMed ID: 24851031
[TBL] [Abstract][Full Text] [Related]
16. Development and delivery of a quality improvement program to reduce antipsychotic polytherapy.
Gören JL; Beck SE; Mills BJ; Shtasel DL; Dufresne RL
J Manag Care Pharm; 2010; 16(6):393-401. PubMed ID: 20635830
[TBL] [Abstract][Full Text] [Related]
17. Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals.
Latimer EA; Naidu A; Moodie EE; Clark RE; Malla AK; Tamblyn R; Wynant W
Psychiatr Serv; 2014 Oct; 65(10):1210-7. PubMed ID: 24981557
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and patterns of antipsychotic use in youth at the time of admission and discharge from an inpatient psychiatric facility.
Procyshyn RM; Su J; Elbe D; Liu AY; Panenka WJ; Davidson J; Honer WG; Barr AM
J Clin Psychopharmacol; 2014 Feb; 34(1):17-22. PubMed ID: 24346744
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points.
McMillan SS; Jacobs S; Wilson L; Theodoros T; Robinson G; Anderson C; Mihala G; Wheeler AJ
BMC Psychiatry; 2017 Apr; 17(1):139. PubMed ID: 28407747
[TBL] [Abstract][Full Text] [Related]
20. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
